Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2012; 18(13): 1470-1478
Published online Apr 7, 2012. doi: 10.3748/wjg.v18.i13.1470
Table 1 Clinicopathological features in the examined gastric cancer patients
VariablesNo. of patients
Total cases64
Age (yr)67.5 ± 2.8
Sex (male/female)42/22
Depth of tumor invasion
T132
T220
T39
T43
Lymphnode metastasis
N034
N112
N214
N34
Peritoneal metastasis
Absent56
Present8
Cytology
Negative57
Positive7
Stage
Stage IA25
Stage IB13
Stage II7
Stage III7
Stage IV12
Table 2 Carcinoembryonic antigen values in sera and peritoneal lavage
SourceControlStage I AStage I BStage IIStage IIIStage IV
CEA
PB (ng/mL)Not tested2.09 (1.39-2.78)  2.03 (0.96-3.1)3.06 (2.04-4.07)2.54 (0.38-4.69)7.98 (1.18-15.82)
PL (ng/g protein)56.53 (21.82-91.24)44.17 (27.37-60.96)61.95 (11.98-111.91)83.14 (7.31-187.54)262.63 (7.26-517.26)1234.00 (87.77-2380.22)
CD4/CD8
PB (ratio)5.379 (2.705-8.052)5.595 (3.224-7.967)4.571 (2.057-7.086)5.277 (1.369-9.184)7.999 (3.366-12.632)4.156 (2.228-6.083)
PL (ratio)0.494 (0.338-0.649)0.553 (0.421-0.685)0.697 (0.511-0.883)0.638 (0.395-0.881)1.242 (0.961-1.522)1.158 (0.907-1.408)
CD45RA-/CCR7-
PB (%)60.43 (46.42-74.44)58.29 (48.93-67.64)53.92 (32.65-75.2)57.36 (42.01-72.71)49.01 (29.31-68.71)45.73 (32.79-58.67)
PL (%)81.17 (81.12-93.22)81.67 (76.35-87.01)76.2 (59.43-92.96)72.3 (61.01-83.58)68.36 (58.70-78.02)51.92 (38.34-65.50)
NKT
PB (%)9.19 (5.83-12.54)7.59 (5.63-9.56)9.47 (4.41-14.53)10.71 (1.55-19.87)5.43 (0.54-10.33)7.16 (3.95-10.3)
PL (%)18.1 (9.83-26.37)17.25 (13.54-20.97)15.74 (9.23-22.25)15.38 (7.71-23.04)9.66 (1.2-18.11)9.91 (6.94-12.88)